Category: Finance
-
Infographic – Biotech Index Continues Downward Trend
The Nasdaq Biotechnology Index, an indicator of investor sentiment in an industry based on science, continued heading down during the third quarter of 2023.
-
Biotech Thymus Tissue Process Gains ARPA-H Funding
A company with a process to generate new thymus tissue for immune system functions is receiving a $37 million award from the government’s health breakthrough agency.
-
Small Biz Award Funds Wearable Drug Delivery Patch
A developer of medical devices designed as skin patches received a contract to develop a device to deliver any drug approved by FDA for delivery through the skin.
-
Biotech, Univ. Labs Test Psychoactive Drug as PTSD Therapy
A developer of treatments with psychedelic compounds for brain disorders is partnering with a lab at Yale University to assess methylone as a PTSD therapy.
-
Challenge Seeks Point-of-Care, Home Maternal Health Technologies
A crowdsourced competition offered by NIH is seeking new technologies to monitor the health and detect early problems with new babies and their mothers, at the point of care or in the home.
-
Infographic – Q2 Tech Merger Values Up, Deals Down
The value of mergers and acquisitions in the global technology sector rose for the first time in over a year in the second quarter of 2023, while M&A deal counts dropped somewhat.
-
Small Biz Grant Supports Regenerative Alzheimer’s Treatment
A new award from National Institutes of Health funds preclinical work to prepare for a clinical trial assessing a treatment to reverse brain signaling damage in people with Alzheimer’s disease.
-
Autoimmune Neuro Disease Start-Up Raises $58M
A new company developing treatments for neurological and psychiatric diseases from aberrant immune system activity is raising $58 million in seed funds.
-
NIH Challenge Seeks Early Alzheimer’s Indicators with A.I.
A new crowdsourced competition seeks more robust early indicators of Alzheimer’s disease and related dementias using analytics powered by artificial intelligence.
-
HHS Directs $100M for Covid-19 Venture Investments
The Department of Health and Human Services is allocating $100 million for venture investments in new technologies to prepare for future threats from Covid-19.